These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38941458)

  • 1. Oral microsphere formulation of M2 macrophage-mimetic Janus nanomotor for targeted therapy of ulcerative colitis.
    Luo R; Liu J; Cheng Q; Shionoya M; Gao C; Wang R
    Sci Adv; 2024 Jun; 10(26):eado6798. PubMed ID: 38941458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amelioration of ulcerative colitis
    Sun T; Kwong CHT; Gao C; Wei J; Yue L; Zhang J; Ye RD; Wang R
    Theranostics; 2020; 10(22):10106-10119. PubMed ID: 32929337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bio-adhesive and ROS-scavenging hydrogel microspheres for targeted ulcerative colitis therapy.
    Sun Q; Chen J; Zhao Q; He Z; Tang L; Pu Y; He B
    Int J Pharm; 2023 May; 639():122962. PubMed ID: 37068716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral Delivery of Nanoparticles Loaded With Ginger Active Compound, 6-Shogaol, Attenuates Ulcerative Colitis and Promotes Wound Healing in a Murine Model of Ulcerative Colitis.
    Zhang M; Xu C; Liu D; Han MK; Wang L; Merlin D
    J Crohns Colitis; 2018 Jan; 12(2):217-229. PubMed ID: 28961808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis.
    Xiao B; Xu Z; Viennois E; Zhang Y; Zhang Z; Zhang M; Han MK; Kang Y; Merlin D
    Mol Ther; 2017 Jul; 25(7):1628-1640. PubMed ID: 28143741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral Core-Shell Nanoparticles Embedded in Hydrogel Microspheres for the Efficient Site-Specific Delivery of Magnolol and Enhanced Antiulcerative Colitis Therapy.
    Wang X; Gu H; Zhang H; Xian J; Li J; Fu C; Zhang C; Zhang J
    ACS Appl Mater Interfaces; 2021 Jul; 13(29):33948-33961. PubMed ID: 34261306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An efficient enzyme-triggered controlled release system for colon-targeted oral delivery to combat dextran sodium sulfate (DSS)-induced colitis in mice.
    Li S; Jin M; Wu Y; Jung S; Li D; He N; Lee MS
    Drug Deliv; 2021 Dec; 28(1):1120-1131. PubMed ID: 34121560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colon-targeted hydroxyethyl starch-curcumin microspheres with high loading capacity ameliorate ulcerative colitis via alleviating oxidative stress, regulating inflammation, and modulating gut microbiota.
    Huang D; Wang Y; Xu C; Zou M; Ming Y; Luo F; Xu Z; Miao Y; Wang N; Lin Z; Weng Z
    Int J Biol Macromol; 2024 May; 266(Pt 1):131107. PubMed ID: 38527677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Dual sensitive supramolecular curcumin nanoparticles" in "advanced yeast particles" mediate macrophage reprogramming, ROS scavenging and inflammation resolution for ulcerative colitis treatment.
    Han X; Luo R; Qi S; Wang Y; Dai L; Nie W; Lin M; He H; Ye N; Fu C; You Y; Fu S; Gao F
    J Nanobiotechnology; 2023 Sep; 21(1):321. PubMed ID: 37679849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Injectable Bioadhesive Hydrogels Scavenging ROS and Restoring Mucosal Barrier for Enhanced Ulcerative Colitis Therapy.
    Li D; Li J; Chen T; Qin X; Pan L; Lin X; Liang W; Wang Q
    ACS Appl Mater Interfaces; 2023 Aug; 15(32):38273-38284. PubMed ID: 37530040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomimetic MOF Nanoparticles Delivery of C-Dot Nanozyme and CRISPR/Cas9 System for Site-Specific Treatment of Ulcerative Colitis.
    Ma Y; Gao W; Zhang Y; Yang M; Yan X; Zhang Y; Li G; Liu C; Xu C; Zhang M
    ACS Appl Mater Interfaces; 2022 Feb; 14(5):6358-6369. PubMed ID: 35099925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual targeting total saponins of Pulsatilla of natural polymer crosslinked gel beads with multiple therapeutic effects for ulcerative colitis.
    Zhang MQ; Huang LH; Gong MC; Hong WM; Xie R; Wang J; Zhou LL; Chen ZH
    Eur J Pharm Biopharm; 2024 Jun; 199():114309. PubMed ID: 38704102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effects of Amauroderma rugosum on dextran sulfate sodium-induced ulcerative colitis through the regulation of macrophage polarization and suppression of oxidative stress.
    Li J; Luo X; Shiu PH; Cheng Y; Nie X; Rangsinth P; Lau BWM; Zheng C; Li X; Li R; Lee SM; Fu C; Seto SW; Zhang J; Leung GP
    Biomed Pharmacother; 2024 Jul; 176():116901. PubMed ID: 38878683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral nanotherapeutics with enhanced mucus penetration and ROS-responsive drug release capacities for delivery of curcumin to colitis tissues.
    Huang Y; Canup BSB; Gou S; Chen N; Dai F; Xiao B; Li C
    J Mater Chem B; 2021 Feb; 9(6):1604-1615. PubMed ID: 33471012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colon tissue-accumulating mesoporous carbon nanoparticles loaded with
    Zhang L; Gui S; Xu Y; Zeng J; Wang J; Chen Q; Su L; Wang Z; Deng R; Chu F; Liu W; Jin X; Lu X
    Theranostics; 2021; 11(7):3417-3438. PubMed ID: 33537095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced therapeutic efficacy of a novel colon-specific nanosystem loading emodin on DSS-induced experimental colitis.
    Wang D; Sun M; Zhang Y; Chen Z; Zang S; Li G; Li G; Clark AR; Huang J; Si L
    Phytomedicine; 2020 Nov; 78():153293. PubMed ID: 32777486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral administration of chondroitin sulfate-functionalized nanoparticles for colonic macrophage-targeted drug delivery.
    Zhang X; Ma Y; Ma L; Zu M; Song H; Xiao B
    Carbohydr Polym; 2019 Nov; 223():115126. PubMed ID: 31426992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyaluronic acid modified oral drug delivery system with mucoadhesiveness and macrophage-targeting for colitis treatment.
    Zhang Y; Ma R; You C; Leng X; Wang D; Deng S; He B; Guo Z; Guan Z; Lei H; Yu J; Zhou Q; Xing J; Dong Y
    Carbohydr Polym; 2023 Aug; 313():120884. PubMed ID: 37182972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific accumulation of orally administered redox nanotherapeutics in the inflamed colon reducing inflammation with dose-response efficacy.
    Vong LB; Mo J; Abrahamsson B; Nagasaki Y
    J Control Release; 2015 Jul; 210():19-25. PubMed ID: 25998050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage-Derived Extracellular Vesicles-Coated Palladium Nanoformulations Modulate Inflammatory and Immune Homeostasis for Targeting Therapy of Ulcerative Colitis.
    Cheng J; Zhang Y; Ma L; Du W; Zhang Q; Gao R; Zhao X; Chen Y; Jiang L; Li X; Li B; Zhou Y
    Adv Sci (Weinh); 2023 Nov; 10(33):e2304002. PubMed ID: 37807805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.